Butterfly rash (malar rash) - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱ 6 min read ✅ Medically reviewed
```html Butterfly Rash (Malar Rash) – A Complete Medical Guide

Butterfly Rash (Malar Rash) – A Complete Medical Guide

Overview

The “butterfly rash,” also called a malar rash, is a characteristic red or violaceous rash that spreads across the cheeks and bridge of the nose in a shape that resembles a butterfly’s wings. Although the rash itself is not a disease, it is a hallmark sign of several systemic conditions—most notably systemic lupus erythematosus (SLE). It can also appear in other autoimmune disorders, viral infections, and drug reactions.

Who it affects: The malar rash is most common in young women of child‑bearing age, reflecting the higher prevalence of SLE in this group. However, it can appear in men, children, and older adults when the underlying condition permits.

Prevalence: Approximately 30–60 % of patients with SLE develop a malar rash at some point in their disease course (Mayo Clinic, 2022). In the United States, SLE affects about 161,000 people, with a female-to-male ratio of roughly 9:1 (CDC, 2023).

Symptoms

The malar rash is often part of a broader symptom picture. Below is a comprehensive list of signs that may accompany the rash.

Primary Rash Features

  • Distribution: Symmetrical redness over both cheeks and nasal bridge; spares the nasolabial folds.
  • Color: Pink to deep red or purplish; may appear dusky or edematous.
  • Texture: Typically flat (macular) or slightly raised (papular); can be scaly if photosensitivity is involved.
  • Duration: Persists for days to weeks; may worsen after sun exposure.
  • Trigger: Ultraviolet (UV) light, heat, or certain medications.

Associated Systemic Symptoms (most common in lupus)

  • Joint pain or swelling (arthralgia/arthritis)
  • Fatigue and low‑grade fever
  • Hair loss (alopecia)
  • Oral or nasal ulcers
  • Raynaud’s phenomenon (color changes in fingers with cold)
  • Kidney involvement (proteinuria, hematuria)
  • Chest pain or shortness of breath (pleuritis, pericarditis)
  • Neurological symptoms (headaches, seizures, cognitive changes)

Other Rash‑Related Findings

  • Photosensitivity: rash flares after 15–30 minutes of sun exposure.
  • Discoid lesions: coin‑shaped, scarring plaques, especially on the scalp.
  • Subacute cutaneous lupus lesions: annular or papulosquamous plaques on sun‑exposed skin.

Causes and Risk Factors

The malar rash does not have a single cause; it is a dermatologic manifestation of underlying systemic processes.

Autoimmune Diseases

  • Systemic Lupus Erythematosus (SLE): The most frequent cause. Autoantibodies (anti‑dsDNA, anti‑Sm, ANA) trigger immune complex deposition in the skin.
  • Dermatomyositis: May produce a heliotrope rash on eyelids and a “shawl” distribution that can overlap the cheeks.
  • Sjögren’s syndrome, rheumatoid arthritis, mixed connective tissue disease: Less common, but can produce a malar‑type rash.

Infections

  • Parvovirus B19 (fifth disease) – “slapped‑cheek” appearance.
  • Measles, rubella, and erythema infectiosum can mimic a malar rash.

Drug‑Induced Causes

  • Hydralazine, procainamide, and certain anti‑seizure meds can precipitate a lupus‑like syndrome with a malar rash.
  • Antibiotics (e.g., minocycline) and biologics may cause photosensitive rashes.

Risk Factors

  • Female sex (especially ages 15‑45)
  • Genetic predisposition – HLA‑DR2, HLA‑DR3 alleles
  • Family history of autoimmune disease
  • Smoking (increases risk of SLE and worsens skin involvement)
  • Excessive UV exposure without protection

Diagnosis

Diagnosing a butterfly rash involves a combination of clinical evaluation, laboratory testing, and sometimes skin biopsy.

Clinical Assessment

  1. History taking: Onset, triggers (sun, drugs), accompanying systemic symptoms, family history.
  2. Physical exam: Careful inspection of the face, noting sparing of nasolabial folds, texture, and any scaling.

Laboratory Tests

  • Antinuclear antibody (ANA) – positive in ~95 % of SLE patients (NIH, 2022).
  • Anti‑double‑stranded DNA (anti‑dsDNA) – more specific for SLE.
  • Anti‑Smith (anti‑Sm) antibodies – highly specific for SLE.
  • Complement levels (C3, C4) – often low during active disease.
  • Complete blood count, renal function, urinalysis – to assess systemic involvement.

Skin Biopsy (when needed)

A 4‑mm punch biopsy stained with hematoxylin‑eosin and immunofluorescence can reveal:

  • Interface dermatitis with basal keratinocyte vacuolization.
  • Deposits of IgG, IgM, and C3 at the dermal‑epidermal junction (“lupus band test”).

Differential Diagnosis

Conditions that can mimic a malar rash include rosacea, seborrheic dermatitis, contact dermatitis, and drug eruptions. Distinguishing features (e.g., papules with telangiectasia in rosacea, greasy scales in seborrheic dermatitis) guide clinicians.

Treatment Options

Treatment is directed at the underlying disease and at controlling the skin manifestation.

Topical Therapies

  • High‑potency corticosteroids (e.g., clobetasol 0.05%): Applied once daily for 2–4 weeks; taper as rash improves.
  • Calcineurin inhibitors (tacrolimus 0.1% ointment): Useful for steroid‑sparing, especially on delicate facial skin.
  • Sun‑blocking agents: Broad‑spectrum sunscreen SPF 30‑50, reapplied every 2 hours outdoors.

Systemic Medications

  • Hydroxychloroquine (HCQ): First‑line antimalarial for cutaneous lupus; 200–400 mg daily improves rash in 70‑80 % of patients (Cleveland Clinic, 2021).
  • Systemic glucocorticoids: Short courses (prednisone 10‑30 mg daily) for severe or rapidly advancing rash.
  • Immunosuppressants: Azathioprine, methotrexate, or mycophenolate mofetil for refractory cases.
  • Biologics: Belimumab (anti‑BLyS) or rituximab (anti‑CD20) in refractory SLE with persistent skin disease.

Lifestyle & Adjunct Measures

  • Strict photoprotection (clothing, hats, UV‑blocking lenses).
  • Smoking cessation – improves treatment response.
  • Stress reduction techniques (mindfulness, yoga) – may lower disease flares.

Living with Butterfly Rash (Malar Rash)

Managing a malar rash is a day‑to‑day commitment that blends medical treatment with practical self‑care.

Skin‑Care Routine

  1. Gentle cleansing: Use fragrance‑free, non‑scrubbing cleansers twice daily.
  2. Moisturize: Apply a hypoallergenic moisturizer within 5 minutes of washing to lock in hydration.
  3. Medication adherence: Take HCQ consistently; arrange pharmacy reminders.

Sun Safety

  • Apply sunscreen 15 minutes before going outdoors; use at least 2 mg/cmÂČ of product.
  • Reapply after swimming or sweating.
  • Prefer shade and protective clothing; wide‑brimmed hats reduce facial UV exposure by up to 90 %.

Monitoring & Follow‑Up

  • Schedule rheumatology visits every 3–6 months (more often if disease is active).
  • Keep a symptom diary noting flare triggers, rash severity (use a 0‑10 visual analog scale), and medication side effects.
  • Annual eye exam if on hydroxychloroquine (risk of retinal toxicity after >5 years).

Psychosocial Support

Visible facial rashes can affect self‑esteem. Consider:

  • Support groups (local lupus foundations or online communities).
  • Consultation with a dermatologist experienced in cosmetic camouflage.
  • Referral to a mental‑health professional if anxiety or depression develops.

Prevention

While the rash itself cannot always be prevented, reducing the risk of flares and protecting the skin are key.

  • Photoprotection: Daily sunscreen, protective clothing, avoid peak UV hours (10 am‑2 pm).
  • Avoid known photosensitizing drugs: Discuss alternatives with your physician.
  • Maintain a healthy lifestyle: Balanced diet, regular exercise, adequate sleep.
  • Quit smoking: Smoking doubles the risk of cutaneous lupus flares (CDC, 2023).
  • Vaccinations: Stay up‑to‑date (influenza, pneumococcal) to prevent infections that could trigger systemic flares.

Complications

If the underlying disease is left untreated or poorly controlled, several complications can arise.

  • Disfiguring scarring: Persistent rash may lead to atrophy or hyperpigmentation.
  • Photosensitivity reactions: Severe sunburn‑like eruptions increasing skin cancer risk.
  • Systemic organ damage: Kidney failure, neuropsychiatric lupus, pulmonary hypertension.
  • Medication toxicity: Long‑term steroids lead to osteoporosis, diabetes, hypertension.
  • Psychological impact: Depression, social withdrawal, reduced quality of life.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe facial swelling accompanied by difficulty breathing or swallowing.
  • Rapid onset of high fever (≄ 38.5 °C / 101.3 °F) with a spreading rash.
  • Chest pain, shortness of breath, or palpitations suggesting pericarditis or pulmonary involvement.
  • Neurologic changes – severe headache, confusion, seizures, or sudden vision loss.
  • Acute kidney injury signs – reduced urine output, swelling of legs, or dark urine.

These symptoms may indicate a severe lupus flare or an allergic/drug reaction that requires immediate treatment.

Sources: Mayo Clinic. “Systemic Lupus Erythematosus.” 2022. | CDC. “Lupus Data & Statistics.” 2023. | NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. 2022. | Cleveland Clinic. “Cutaneous Lupus Management.” 2021. | WHO. “Autoimmune Diseases Fact Sheet.” 2023.

```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References